Apellis Pharmaceuticals, Inc. - COM (APLS)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
266
Total Shares
117M
Shares change
-882K
Total reported value, excl. options
$3.38B
Value change
-$73.7M
Put/Call ratio
0.28
Number of buys
130
Number of sells
-129
Price
$28.84
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.